Skip to content

Supplier News

Glenmark cleared to market Evista generic

Glenmark cleared to market Evista generic

Glenmark Pharmaceuticals Inc. USA has received final approval from the Food & Drug Administration for raloxifene hydrochloride tablet. Glenmark said Wednesday that its raloxifene product is a generic equivalent of Evista tablets (60 mg) from Eli Lilly and Co.

Twinlab announces CEO succession

Twinlab announces CEO succession

Nutritional supplements maker Twinlab Consolidated Holdings Inc. has named Naomi Whittel as president and chief executive officer. Twinlab said Whittel takes the reins from Tom Tolworthy, who is leaving the company to pursue other ventures.

GlaxoSmithKline CEO Andrew Witty to retire

GlaxoSmithKline CEO Andrew Witty to retire

Sir Andrew Witty, chief executive officer of GlaxoSmithKline plc, plans to retire from the company next year. GSK announced Witty’s retirement Thursday in releasing its 2015 annual report to shareholders. Plans call for Witty to step down from the CEO post on March 31, 2017.

CHPA announces new officers, board members

CHPA announces new officers, board members

The Consumer Healthcare Products Association (CHPA) has elected officers and members to its board of directors. CHPA said Wednesday that Patrick Lockwood-Taylor, vice president of Personal Health Care North America and Digestive Wellness Design for Procter & Gamble Co.